BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10855999)

  • 1. Long-term continuum of care for people living with HIV/AIDS.
    Corless IB; Nicholas PK
    J Urban Health; 2000 Jun; 77(2):176-86. PubMed ID: 10855999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV/AIDS and long-term care: a state perspective.
    Hoos D; Chorost SE; Chesnut TJ
    J Urban Health; 2000 Jun; 77(2):232-43. PubMed ID: 10856004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus transmission at each step of the care continuum in the United States.
    Skarbinski J; Rosenberg E; Paz-Bailey G; Hall HI; Rose CE; Viall AH; Fagan JL; Lansky A; Mermin JH
    JAMA Intern Med; 2015 Apr; 175(4):588-96. PubMed ID: 25706928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic impact of delaying or preventing AIDS in persons with HIV.
    Pinkerton SD; Holtgrave DR
    Am J Manag Care; 1999 Mar; 5(3):289-98. PubMed ID: 10351025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery systems for the care of persons with HIV infection and AIDS.
    Morrison C
    Nurs Clin North Am; 1993 Jun; 28(2):317-33. PubMed ID: 8516176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV/AIDS data on the Internet.
    Gillespie G
    Health Data Manag; 1999 Aug; 7(8):24, 26-7. PubMed ID: 10557698
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of complementary therapies to treat patients with HIV/AIDS.
    Palmer R
    Nurs Stand; 2008 Aug 20-26; 22(50):35-41. PubMed ID: 18767438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current antiretroviral therapy and its impact on human immunodeficiency virus-related wasting.
    Sherer R
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):92-7. PubMed ID: 9625390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Human Immunodeficiency Virus Care Continuum in China: 1985-2015.
    Ma Y; Dou Z; Guo W; Mao Y; Zhang F; McGoogan JM; Zhao Y; Zhao D; Wu Y; Liu Z; Wu Z
    Clin Infect Dis; 2018 Mar; 66(6):833-839. PubMed ID: 29216405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to adherence to highly active antiretroviral therapy as expressed by people living with HIV/AIDS.
    Proctor VE; Tesfa A; Tompkins DC
    AIDS Patient Care STDS; 1999 Sep; 13(9):535-44. PubMed ID: 10813033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States.
    Hall HI; Frazier EL; Rhodes P; Holtgrave DR; Furlow-Parmley C; Tang T; Gray KM; Cohen SM; Mermin J; Skarbinski J
    JAMA Intern Med; 2013 Jul; 173(14):1337-44. PubMed ID: 23780395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The road to success. Long-term prognosis for persons living with HIV in Denmark - time trends and risk factors.
    Lohse N
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Oct; 47(RR-20):1-58. PubMed ID: 9809743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological considerations in human immunodeficiency virus-infected adults in the intensive care unit.
    DeFreitas AA; D'Souza TL; Lazaro GJ; Windes EM; Johnson MD; Relf MV
    Crit Care Nurse; 2013 Apr; 33(2):46-56. PubMed ID: 23547125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and responses in providing palliative care for people living with HIV/AIDS.
    Huang YT
    Int J Palliat Nurs; 2013 May; 19(5):218, 220-5. PubMed ID: 23971305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary care and specialty care in the age of HAART.
    Soloway B
    AIDS Clin Care; 1997 May; 9(5):37-9. PubMed ID: 11364297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV/AIDS and return to work: a literature review one-decade post-introduction of combination therapy (HAART).
    Braveman B; Levin M; Kielhofner G; Finlayson M
    Work; 2006; 27(3):295-303. PubMed ID: 17006006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virologic suppression among HIV-infected US Air Force members in a highly-structured programme with free access to care.
    Matthews PE; Le T; Delmar J; Okulicz JF
    Int J STD AIDS; 2015 Nov; 26(13):951-9. PubMed ID: 25505041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.